Cargando…
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhib...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314076/ https://www.ncbi.nlm.nih.gov/pubmed/35146812 http://dx.doi.org/10.1111/ejn.15623 |
_version_ | 1784754231771660288 |
---|---|
author | Schweimer, Judith V. Brouard, Julia T. Li, Yan Sánchez, Connie Sharp, Trevor |
author_facet | Schweimer, Judith V. Brouard, Julia T. Li, Yan Sánchez, Connie Sharp, Trevor |
author_sort | Schweimer, Judith V. |
collection | PubMed |
description | The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5‐HT(3)R‐expressing interneurons (5‐HT(3)R‐INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5‐HT(3)R‐INs whilst simultaneously recording pyramidal neuron activity using cortical slow‐wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane‐anaesthetised rats. 5‐HT(3)R‐INs were identified by a short‐latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular‐labelling found such neurons had the morphological and immunohistochemical properties of 5‐HT(3)R‐INs: basket cell or bipolar cell morphology, expression of 5‐HT(3)R‐IN markers and parvalbumin‐immunonegative. Vortioxetine inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5‐HT(3)R antagonist ondansetron inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs. However unlike vortioxetine, ondansetron did not decrease cortical slow‐wave oscillations, suggesting a dissociation between this effect and inhibition of 5‐HT(3)R‐INs. The 5‐HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN‐evoked) 5‐HT(3)R‐INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5‐HT(3)R‐mediated mechanism. |
format | Online Article Text |
id | pubmed-9314076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93140762022-07-30 In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine Schweimer, Judith V. Brouard, Julia T. Li, Yan Sánchez, Connie Sharp, Trevor Eur J Neurosci Molecular and Synaptic Mechanisms The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5‐HT(3)R‐expressing interneurons (5‐HT(3)R‐INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5‐HT(3)R‐INs whilst simultaneously recording pyramidal neuron activity using cortical slow‐wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane‐anaesthetised rats. 5‐HT(3)R‐INs were identified by a short‐latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular‐labelling found such neurons had the morphological and immunohistochemical properties of 5‐HT(3)R‐INs: basket cell or bipolar cell morphology, expression of 5‐HT(3)R‐IN markers and parvalbumin‐immunonegative. Vortioxetine inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5‐HT(3)R antagonist ondansetron inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs. However unlike vortioxetine, ondansetron did not decrease cortical slow‐wave oscillations, suggesting a dissociation between this effect and inhibition of 5‐HT(3)R‐INs. The 5‐HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN‐evoked) 5‐HT(3)R‐INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5‐HT(3)R‐mediated mechanism. John Wiley and Sons Inc. 2022-03-03 2022-03 /pmc/articles/PMC9314076/ /pubmed/35146812 http://dx.doi.org/10.1111/ejn.15623 Text en © 2022 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Molecular and Synaptic Mechanisms Schweimer, Judith V. Brouard, Julia T. Li, Yan Sánchez, Connie Sharp, Trevor In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title |
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title_full |
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title_fullStr |
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title_full_unstemmed |
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title_short |
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
title_sort | in vivo electrophysiological study of the targeting of 5‐ht(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine |
topic | Molecular and Synaptic Mechanisms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314076/ https://www.ncbi.nlm.nih.gov/pubmed/35146812 http://dx.doi.org/10.1111/ejn.15623 |
work_keys_str_mv | AT schweimerjudithv invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine AT brouardjuliat invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine AT liyan invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine AT sanchezconnie invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine AT sharptrevor invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine |